IE
EPIX

Israel Englander’s ESSA Pharma EPIX Stock Holding History

Israel Englander’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,052
Closed -$119K – 6047
2024
Q1 		$119K Buy
+14,052
New +$123K ﹤0.01% 5535
2023
Q4 		– Sell
-473,556
Closed -$1.46M – 6192
2023
Q3 		$1.46M Buy
473,556
+4,554
+1% +$13.1K ﹤0.01% 3867
2023
Q2 		$1.27M Buy
469,002
+49,935
+12% +$146K ﹤0.01% 3847
2023
Q1 		$1.25M Buy
419,067
+244,592
+140% +$719K ﹤0.01% 3890
2022
Q4 		$440K Sell
174,475
-232,286
-57% -$667K ﹤0.01% 4835
2022
Q3 		$740K Buy
406,761
+80,031
+24% +$211K ﹤0.01% 4595
2022
Q2 		$1.03M Buy
326,730
+124,683
+62% +$697K ﹤0.01% 4341
2022
Q1 		$1.25M Buy
202,047
+66,497
+49% +$585K ﹤0.01% 4324
2021
Q4 		$1.93M Sell
135,550
-113,137
-45% -$1.26M ﹤0.01% 3816
2021
Q3 		$1.99M Buy
248,687
+226,369
+1,014% +$3.6M ﹤0.01% 3930
2021
Q2 		$638K Sell
22,318
-17,651
-44% -$513K ﹤0.01% 5092
2021
Q1 		$1.16M Sell
39,969
-800
-2% -$18.6K ﹤0.01% 4073
2020
Q4 		$486K Sell
40,769
-22,207
-35% -$156K ﹤0.01% 4217
2020
Q3 		$435 Buy
+62,976
New +$427K ﹤0.01% 3648

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Israel Englander's EPIX Position: Q2 2024 in Review

Israel Englander sold out of ESSA Pharma (EPIX) in Q2 2024, closing a stake of 14,052 shares — an estimated $119K sold.

Israel Englander first reported a position in EPIX in Q3 2020 and held it in 14 quarters. The position peaked at $1.99M in Q3 2021. 31 funds tracked by Wall St. Rank hold EPIX as of Q2 2024.

  • Israel Englander reported no remaining ESSA Pharma position as of Q2 2024 after selling out during the quarter.
  • Israel Englander sold 14,052 ESSA Pharma shares in Q2 2024, an estimated $119K.
  • Israel Englander first reported a position in ESSA Pharma in Q3 2020 and held it in 14 quarters.
  • Israel Englander's ESSA Pharma position peaked at $1.99M in Q3 2021.
  • 31 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.